Improving the use of continuous glucose monitoring in primary care for diabetes management
Support to Adopt and Retain Technology (StART) CGM: A pilot study to support continuous glucose monitoring in primary care
This study is looking at how to help people with insulin-requiring type 2 diabetes use continuous glucose monitoring devices better, so they can manage their diabetes more easily and effectively.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10894244 on NIH RePORTER |
What this research studies
This research focuses on enhancing the adoption and retention of continuous glucose monitoring (CGM) devices among patients with insulin-requiring type 2 diabetes. It aims to identify and address barriers that prevent patients from using CGM effectively in primary care settings. By employing Implementation Science, the study will explore factors at the patient, provider, and health system levels that influence CGM usage. The goal is to develop strategies that support patients in managing their diabetes more effectively through better use of technology.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults with insulin-requiring type 2 diabetes who are eligible for continuous glucose monitoring.
Not a fit: Patients who do not have diabetes or those who are not insulin-dependent may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diabetes management and better health outcomes for patients using continuous glucose monitoring.
How similar studies have performed: Previous research has shown that targeted interventions can improve the adoption and retention of diabetes management technologies, indicating potential for success in this approach.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Mizokami-Stout, Kara R — University of Michigan at Ann Arbor
- Study coordinator: Mizokami-Stout, Kara R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.